Blogbeiträge | Gen Re

Unsere Perspektive

Stroke in Younger Adults - Have Improvements Reached Their Limit?

Von Dr. Chris Ball |December 18, 2017|English

Age remains the most consistent risk factor for ischaemic stroke. Surprisingly then an estimated 10% of diagnoses are now seen in people below the age of 50. In many countries vigorous management of vascular risk coupled to improved stroke services...
Lesen Sie mehr
Lump Sum Benefits - The Experience in New Zealand

Von Li Wen Beh and Winncy Wong |November 28, 2017|English

Lesen Sie mehr
Progress in the Management of Multiple Sclerosis

Von Dr. Chris Ball |November 23, 2017|English

Multiple Sclerosis (MS) presents a challenge to insurers due to its complex, unpredictable course. MS is a covered condition in “Critical Illness” insurance policies sold in markets across Asia, in the UK and Ireland, South Africa, New Zealand...
Lesen Sie mehr
Genetic Testing and the Power of Knowledge

Von Annika Schilling |November 16, 2017|English

Using genetic testing to make treatment decisions on serious medical conditions, such as cancer, is becoming more common. Approved tests number in the thousands, and the costs associated with genome sequencing have fallen sharply. Most genetic tests...
Lesen Sie mehr
How Deep Brain Stimulation Helps Manage Neurological Disorders

Von Dr. Chris Ball |October 24, 2017|English

Using electrical stimulation to manage brain disorders has a long and chequered history. Deep Brain Stimulation (DBS) is the latest. It involves implanting electrodes, connected to a computerized pulse generator, deep into the structure of the brain....
Lesen Sie mehr
Accelerated Underwriting – Get on The Right Track

Von Keith Brown |September 20, 2017|English

Seeing the many different projects being pursued by direct companies is one of the most interesting aspects of working in reinsurance. Just recently I’ve noticed how many life carriers are going down the Accelerated Underwriting (AU) route. It’s...
Lesen Sie mehr